Continuous hypothalamic K_ATP activation blunts glucose counter-regulation in vivo in rats and suppresses K_ATP conductance in vitroBEALL, Craig; HAYTHORNE, Elizabeth; XIAONING FAN et al.Diabetologia (Berlin). 2013, Vol 56, Num 9, pp 2088-2092, issn 0012-186X, 5 p.Article

Inhibition of insulin secretion as a new drug target in the treatment of metabolic disordersBONDO HANSEN, J; ARKHAMMAR, Per O. G; BODVARSDOTTIR, Thora B et al.Current medicinal chemistry. 2004, Vol 11, Num 12, pp 1595-1615, issn 0929-8673, 21 p.Article

Synthesis of carbon-14 and stable isotope labelled NN414: a potent potassium channel openerJOHANSEN, Steen K; KRISTENSEN, Jesper B; MÜLLER, Lars K et al.Journal of labelled compounds & radiopharmaceuticals. 2004, Vol 47, Num 2, pp 127-138, issn 0362-4803, 12 p.Article

The effects of NN414, a SUR1 /Kir6.2 selective potassium channel opener in subjects with type 2 diabetesZDRAVKOVIC, M; KRUSE, M; ROST, K. L et al.Experimental and clinical endocrinology & diabetes. 2007, Vol 115, Num 6, pp 405-406, issn 0947-7349, 2 p.Article

Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectivesHANSEN, John Bondo.Current medicinal chemistry. 2006, Vol 13, Num 4, pp 361-376, issn 0929-8673, 16 p.Article